Hypermarcas (OTCMKTS:HYPMY) Stock Price Crosses Below Fifty Day Moving Average - Here's What Happened

Key Points

• Hypermarcas stock fell below its fifty-day moving average, trading as low as $4.27 before last settling at $4.44 with a volume of 373 shares.
• Analysts are optimistic about Hypermarcas, with Scotiabank upgrading the stock to a "strong-buy" rating and the consensus rating remaining "Strong Buy."
• The company announced a dividend payment of $0.0345 per share with a significant yield of 281% for investors of record as of July 1st.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $4.54 and traded as low as $4.27. Hypermarcas shares last traded at $4.44, with a volume of 373 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Scotiabank raised Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Strong Buy".

Hypermarcas Stock Up 3.6%

The firm has a market capitalization of $2.81 billion, a price-to-earnings ratio of 21.14 and a beta of 0.86. The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63. The firm has a 50 day moving average price of $4.54 and a two-hundred day moving average price of $4.13.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.12 earnings per share for the quarter. Hypermarcas had a return on equity of 6.19% and a net margin of 11.28%.

Hypermarcas Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be given a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a yield of 281.0%. Hypermarcas's payout ratio is 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.